ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

Preventive Oncology Announcement Withdrawn For Modification

April 3, 1981

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

New Evidence Shows Polyp Removal Lowers Death Rate at 23-Year Follow-up

February 24, 2012

Number of Cancer Deaths Rise Slightly Due To Population Growth And Aging.

February 22, 2008

NCI Low Fat Diet Study For Stage 2 Breast Cancer Will Include Postmenopausal Tamxifen Therapy

September 20, 1985

FDA Likely To Change Procedures For Patient Interaction, Official Says

November 10, 1995